No qualifying author-owned investment thesis was confirmed in this post.
no investment thesis
Score2
Comments3
▶ Full Post Text
The market still trades SM at a significant discount compared to peers like DVN or FANG. Do you think the 'integration risk' of the recent acquisition justifies such a low multiple, or are we looking at a clear rerating candidate once the debt hits the $2B target?